Compare Pabrik Kertas Tjiwi Kimia Tbk. (TKIM) vs Tempo Scan Pacific Tbk. (TSPC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Pabrik Kertas Tjiwi Kimia Tbk. vs Tempo Scan Pacific Tbk. — how do they compare? Pabrik Kertas Tjiwi Kimia Tbk. trades at Rp6,125 (market cap 18.99T, 117.4K 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,620 (market cap 11.64T, 5.1K 24h volume). The key difference: Pabrik Kertas Tjiwi Kimia Tbk. is the larger of the two by market cap, and Pabrik Kertas Tjiwi Kimia Tbk. is more actively traded (117.4K versus 5.1K). Which is the better fit depends on your goals.
| TKIM | TSPC | |
|---|---|---|
Market Cap | 18.99T | 11.64T |
Volume | 117.4K | 5.1K |
Lot | 1.17K | 51 |
Turnover | 714.91M | 13.27M |
Average Price | 6,089.48 | 2,601.96 |
Value | 714.91M | 13.27M |
Indicative Equilibrium Price | 6,100 | 2,600 |
Indicative Equilibrium Volume | 4.5K | 1 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Pabrik Kertas Tjiwi Kimia Tbk.
PT Pabrik Kertas Tjiwi Kimia Tbk (the Company) was established in 1972 under the name of PT Tjiwi Kimia and was later renamed to become PT Pabrik Kertas Tjiwi Kimia in 1974. The total production capacity as of December 31, 1999 for the printing and writing paper stood at 1.014.000 tonnes per annum, packaging and converted products at 78.000 tonnes per annum and stationery at 275.000 tonnes per annum.The Company started its commercial production in 1977.
Read more on TKIM →About Tempo Scan Pacific Tbk.
PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Read more on TSPC →
